About Isolation Sciences
Isolation Sciences is a company based in Williamsville (United States) founded in 2006. Isolation Sciences has raised $150 thousand across 1 funding round from investors including Excell. Isolation Sciences operates in a competitive market with competitors including G-Con Manufacturing, Comecer, NuAire, Noroit and Landauer, among others.
- Headquarter Williamsville, United States
- SectorsHealthcare
- Email••••••••
- Website isolationsciences.com
- Social LinkedIn
- Total Equity Funding$150K (USD)
in 1 rounds
- Latest Funding Round$150K (USD), Seed
Oct 2013
- Investors
Funding Insights of Isolation Sciences
Isolation Sciences has successfully raised a total of $150K through 1 strategic funding round. The most recent funding activity was a Seed round of $150 thousand completed in October 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $150,000
- Total Rounds 1
- Last Round Seed — $150,000
- First Round $150,000
(Oct 2013)
- Investors Count 1
All 1 funding rounds of Isolation Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2013 | $150,000 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Isolation Sciences
Isolation Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Excell.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Excell is recognized as a venture capital fund in NY. | 2006 | excellny.com | United States |
Investor details for Isolation Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Isolation Sciences
2 dated milestones of Isolation Sciences across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Isolation Sciences is founded.
- Funding First funding round of $150K.
Competitors of Isolation Sciences
Isolation Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as G-Con Manufacturing, Comecer, NuAire, Noroit and Landauer, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gconbio.com | 2009 | College Station, United States | $13M | 43 | Builds and installs prefabricated, autonomous cleanrooms | |
| comecer.com | 1974 | Castel Bolognese, Italy | $10.57M | 4 | Protective equipment and containment systems for nuclear medicine, nuclear power plants and aseptic manufacturing | |
| nuaire.com | 1971 | Plymouth, United Kingdom | – | 265 | Laboratory safety equipment is manufactured for research and industrial use. | |
| noroitlabo.com | 2006 | Bouaye, France | $496,282 | – | Developer of protective equipment against biological risks for research, pharma and hospital sectors | |
| landauer.com | 1954 | Glenwood, United States | – | – | Radiation monitoring and protection | |
| virustatic.com | 2009 | Stockport, United Kingdom | – | 1 | Anti-viral technology for face masks is developed by Virustatic. | |
| biosci-intl.com | 1996 | Rockville, United States | – | 10 | Manufactures air sampling equipment to detect contamination in food, pharmaceutical, and hospital environments. | |
| vitrologybiotech.com | 2007 | Glasgow, United Kingdom | – | – | Biosafety testing for biologics is conducted to ensure compliance. | |
| genetoo.com | 2017 | Rehoboth Beach, United States | – | – | Aseptic surfaces for medical implants are created via laser technology. |
Detailed competitors of Isolation Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Isolation Sciences
10 companies that operate in the same segment as Isolation Sciences (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Isolation Sciences
Isolation Sciences was founded in 2006 and raised its 1st funding round 7 years after it was founded.
Isolation Sciences is headquartered in Williamsville, United States. It is registered at Williamsville, New York, United States.
Isolation Sciences is a funded company, having raised a total of $150K across 1 funding round to date. The company's 1st funding round was a Seed of $150K, raised on Oct 2013.
Isolation Sciences has developed a continuous access port retrofit kit for fume hoods that claims to significantly improve containment, access, energy efficiency and sustainability of fume hoods used in various chemical and biological industries. The system (called Fume Hood CAP) is a patented design consisting of two movable access ports mounted on a track system, allowing the ports to easily slide back and forth. The track is integrated into a transparent barrier film resulting in unobstructed and continuous access while allowing full view of the fume hood workbench. The company has collaborations with Seimens, Pharmaceutical Containment Technologies, and Airex Co. Ltd, and offers installations services at multiple locations within the US, and in India, Japan, Macedonia, and Australia.
Isolation Sciences's top competitors include G-Con Manufacturing, Comecer and NuAire.
Isolation Sciences has 1 investor. Key investors include Excell.